Tero Rautio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tero Rautio has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Anne Tuomisto
Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland
42 shared publications - Juha P. Väyrynen
Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland
42 shared publications - Markus J. Mäkinen
Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland
42 shared publications - Päivi Sirniö
Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland
42 shared publications - Henna Karjalainen
University of Oulu 3 Cancer and Translational Medicine Research Unit Oulu, Finland
41 shared publications - Juha Saarnio
Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland
41 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Figure S2. Cutpoint selection plots for SMI and SMD
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Figure S2. Cutpoint selection plots for SMI and SMD
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Data from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Background:Low skeletal muscle index (SMI) and skeletal muscle density (SMD) are associated with poor postoperative outcomes in colorectal cancer. However, standardized diagnostic thresholds remain undefined. Methods:In total, 927 patients with stage I to IV colorectal cancer were included. Preoperative computed tomography was used to determine body composition parameters. Optimal stratification was applied to identify the sex-specific and body mass index (BMI)–specific SMD and SMI cutoffs. SMD and SMI were analyzed as continuous variables relative to clinicopathologic features, systemic inflammatory markers, and sex-specific quartiles in survival analyses using Kaplan–Meier and Cox regression methods. Results:Optimal stratification did not yield reproducible cutoff values for SMI or SMD. In multivariable analysis, low SMD and SMI were associated with female sex, older age, and BMI, whereas tumor-related factors were not associated with either measure. Low SMD was associated with systemic inflammation, including elevated circulating C-reactive protein and interleukin 6 (IL6) levels, whereas low SMI showed only a nominal association with elevated IL6 levels after adjustment. Low SMD independently predicted poorer cancer-specific survival [multivariable hazard ratio (HR) for lowest vs. highest SMD = 4.29; 95% confidence interval (CI), 1.86–9.91; P = 0.001] and overall survival (HR for lowest vs. highest SMD = 3.42; 95% CI, 1.62–7.25; P = 0.003) in women but not in men, whereas SMI was not associated with survival. Conclusions:Low SMD is a sex-specific prognostic factor. Incorporating SMD assessment into preoperative risk stratification may enhance individualized management, particularly for female patients. Impact:Survival-based cutoff values for SMD or SMI in colorectal cancer could not be established. Moreover, preoperative body composition reflects patient-related factors rather than tumor-induced changes.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Background:Low skeletal muscle index (SMI) and skeletal muscle density (SMD) are associated with poor postoperative outcomes in colorectal cancer. However, standardized diagnostic thresholds remain undefined. Methods:In total, 927 patients with stage I to IV colorectal cancer were included. Preoperative computed tomography was used to determine body composition parameters. Optimal stratification was applied to identify the sex-specific and body mass index (BMI)–specific SMD and SMI cutoffs. SMD and SMI were analyzed as continuous variables relative to clinicopathologic features, systemic inflammatory markers, and sex-specific quartiles in survival analyses using Kaplan–Meier and Cox regression methods. Results:Optimal stratification did not yield reproducible cutoff values for SMI or SMD. In multivariable analysis, low SMD and SMI were associated with female sex, older age, and BMI, whereas tumor-related factors were not associated with either measure. Low SMD was associated with systemic inflammation, including elevated circulating C-reactive protein and interleukin 6 (IL6) levels, whereas low SMI showed only a nominal association with elevated IL6 levels after adjustment. Low SMD independently predicted poorer cancer-specific survival [multivariable hazard ratio (HR) for lowest vs. highest SMD = 4.29; 95% confidence interval (CI), 1.86–9.91; P = 0.001] and overall survival (HR for lowest vs. highest SMD = 3.42; 95% CI, 1.62–7.25; P = 0.003) in women but not in men, whereas SMI was not associated with survival. Conclusions:Low SMD is a sex-specific prognostic factor. Incorporating SMD assessment into preoperative risk stratification may enhance individualized management, particularly for female patients. Impact:Survival-based cutoff values for SMD or SMI in colorectal cancer could not be established. Moreover, preoperative body composition reflects patient-related factors rather than tumor-induced changes.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S7. Multivariable Cox regression models for CSS, all variables, stages I-III
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S7. Multivariable Cox regression models for CSS, all variables, stages I-III
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Figure S1 illustrates the patient selection process for the study
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Figure S1 illustrates the patient selection process for the study
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S2. Correlations between SMD/SMI and circulating inflammatory factors
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S2. Correlations between SMD/SMI and circulating inflammatory factors
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S3. Sex-specific quartiles for SMI and SMD.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S3. Sex-specific quartiles for SMI and SMD.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S5. Multivariable Cox regression models for OS, all variables
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S5. Multivariable Cox regression models for OS, all variables
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S6. Cox survival analyses for stage I-III CRC patients
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S6. Cox survival analyses for stage I-III CRC patients
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S8. Multivariable Cox regression models for OS, all variables, stages I-III
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S8. Multivariable Cox regression models for OS, all variables, stages I-III
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S4. Multivariable Cox regression models for CSS, all variables
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors
Supplementary Table S4. Multivariable Cox regression models for CSS, all variables